Alkermes Plc news

   Watch this stock
Showing stories 1 - 10 of about 53   

Articles published

ALKS 44.73 +0.25 (0.56%)
price chart
Alkermes plc (ALKS) Submits NDA to U.S. FDA Covering Aripiprazole Lauroxil
Alkermes plc (Nasdaq: ALKS) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of aripiprazole lauroxil, the company's investigational, novel, once-monthly, long-acting injectable atypical ...
Alkermes seeks US FDA approval for aripiprazole lauroxil to treat schizophrenia  pharmabiz.com
Alkermes submits application for schizophrenia drug  Boston Globe
Related articles »  
Alkermes Plc COO Gordon G. Pugh Unloads 16000 Shares (ALKS)
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS) COO Gordon G. Pugh sold 16,000 shares of the stock in a transaction that occurred on Tuesday, August 26th.
Alkermes Plc CFO James M. Frates Sells 16000 Shares (ALKS)  Intercooler
Related articles »  
Alkermes Plc CFO James M. Frates Unloads 16000 Shares (ALKS)
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS) CFO James M. Frates unloaded 16,000 shares of the stock in a transaction dated Wednesday, August 27th.
Morgan Stanley Sees EPS Below Consensus, Robust Pipeline For Alkermes plc
In a report published Thursday, Morgan Stanley analyst David Risinger reiterated an Equal-Weight rating on Alkermes plc (NASDAQ: ALKS).
Related articles »  
Alkermes Plc Receives Consensus Rating of "Buy" from Brokerages (NASDAQ ...
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS) has earned a consensus recommendation of �Buy� from the nine ratings firms that are presently covering the company, AmericanBankingNews.
Related articles »  
Insider Selling: James M. Frates Sells 15000 Shares of Alkermes Plc Stock (ALKS)
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS) CFO James M. Frates sold 15,000 shares of Alkermes Plc stock on the open market in a transaction that occurred on Wednesday, August 13th.
Related articles »  
Insider Selling: Gordon G. Pugh Sells 16000 Shares of Alkermes Plc Stock (ALKS)
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS) COO Gordon G. Pugh sold 16,000 shares of Alkermes Plc stock in a transaction dated Tuesday, August 26th.
Alkermes Plc Price Target Lowered to $56.00 at Credit Suisse (ALKS)
Alkermes Plc logo Investment analysts at Credit Suisse cut their price target on shares of Alkermes Plc (NASDAQ:ALKS) from $57.00 to $56.00 in a note issued to investors on Friday.
Related articles »  
Alkermes Plc Receives Average Rating of �Buy� from Analysts (NASDAQ:ALKS)
Alkermes Plc logo Shares of Alkermes Plc (NASDAQ:ALKS) have earned a consensus rating of �Buy� from the nine ratings firms that are presently covering the company, AnalystRatings.
Alkermes Plc Given Consensus Rating of �Buy� by Brokerages (NASDAQ:ALKS)  sleekmoney
Related articles »  
Alkermes Plc Receives Neutral Rating from Zacks (ALKS)
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS)'s stock had its �neutral� rating restated by Zacks in a research report issued to clients and investors on Wednesday.
Related articles »